IL-2 antibodies in type 1 diabetes and during IL-2 therapy

Guillaume Churlaud, Michelle Rosenzwajg, Patrice Cacoub, David Saadoun, Dominique Valteau-Couanet, Nathalie Chaput, Alberto Pugliese, David Klatzmann

Research output: Contribution to journalArticle

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)2066-2068
Number of pages3
JournalDiabetologia
Volume61
Issue number9
DOIs
StatePublished - Sep 1 2018

Keywords

  • Autoantibodies
  • Autoimmune disease
  • Autoimmunity
  • IL-2
  • Type 1 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Churlaud, G., Rosenzwajg, M., Cacoub, P., Saadoun, D., Valteau-Couanet, D., Chaput, N., Pugliese, A., & Klatzmann, D. (2018). IL-2 antibodies in type 1 diabetes and during IL-2 therapy. Diabetologia, 61(9), 2066-2068. https://doi.org/10.1007/s00125-018-4649-4